Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cethoxacin vs levofloxacin in acute lower respiratory and urinary tract infections
CTR20150136Phase 2Active
- Sponsor
- Nanjing Zhenhua Pharmaceutical Technology Development
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of delafloxacin in urinary tract infection (UTI), complicated urinary tract infection (cUTI), gonococcal urethritis, gonococcal infection of the cervix, pharyngitis, sponsored by Nanjing Zhenhua Pharmaceutical Technology Development. Started Mar 2015; status: active.
02
Drugs
delafloxacin
03
Conditions
urinary tract infection (UTI)complicated urinary tract infection (cUTI)gonococcal urethritisgonococcal infection of the cervixpharyngitis
Beyond the preview
Go deeper on CTR20150136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150136.